Beth Dobbin, a British sprinter who represented Great Britain at the Tokyo Olympics in 2021, has revealed the significant impact of a chronic health condition on her life and career. The 32-year-old athlete from Doncaster has been diagnosed with myalgic encephalomyelitis (ME), a debilitating illness characterised by severe fatigue that does not improve with rest. Her situation has deteriorated significantly in recent years, particularly following bouts of COVID-19 and glandular fever.
:max_bytes(150000):strip_icc():format(jpeg)/beth-dobbin-101626-5d4ea6dd9f7a4582a25042ecf4c659da.jpg)
Since her diagnosis, Dobbin has described her existence as largely confined to bed, spending around 22 hours a day in this state. She has ventured outside her home only five times in 2026, leading to a profound shift in her life. “This kind of fatigue feels like your body’s shutting down. It feels like you are a few days away from death,” she told BBC Sport, reflecting on the stark contrast between her previous life as a professional athlete and her current health struggles.
Dobbin’s challenges began after she contracted COVID and glandular fever shortly after the 2021 Olympics. Initially, she was unaware of her condition, only realising something was wrong when she began experiencing recurring symptoms. “As the season went on, it just kind of got progressively worse,” she recounted, noting how her performance fluctuated between good and bad races.
Despite seeking medical advice and undergoing various tests, Dobbin received no definitive diagnosis for quite some time. What started as persistent fatigue and discomfort morphed into more alarming symptoms, such as dizziness during races and numbness in her legs, which ultimately led her to false start in competitions. After consulting numerous specialists, she finally received her ME diagnosis, a term that encapsulates her myriad symptoms, including muscle aches, joint pain, headaches, and concentration difficulties.
The gravity of her condition has forced Dobbin to reassess her future, which she describes as “very bleak.” She has spent significant time observing the impact of her condition on her family. “You wake up every day and just feel sad. She should be building her life, living her best life,” mentioned her mother, Jean, highlighting the emotional toll the situation has taken not just on Dobbin but on her loved ones as well.
In a powerful show of support for her sister, Dobbin’s sister, Faye, has taken it upon herself to raise awareness and funds for ME research. She plans to run a marathon for the charity ME Research UK, underscoring the urgent need for greater understanding and potential treatments for this debilitating illness. Faye expressed her frustration at being unable to provide more immediate help, given the lack of a cure.
The Cleveland Clinic has noted that ME is a chronic illness that affects a person’s overall well-being, severely limiting their ability to perform everyday tasks. This aligns with Dobbin’s experiences, as she finds even simple activities, like sitting up for an extended period, exhausting. Her routine now revolves around resting and managing her symptoms, a far cry from the demanding training schedule she maintained as an elite athlete.
Despite her struggles, Dobbin’s resilience shines through as she navigates her new reality. Her story serves as a poignant reminder of the unpredictable nature of health and how quickly life can change. As she continues to advocate for awareness surrounding ME, her hope remains that one day better treatments will be available for those affected by the illness.
In conclusion, Beth Dobbin’s journey is an inspirational yet solemn tale of a once-promising athlete grappling with the limitations of chronic illness. It sheds light on the often invisible battles faced by many individuals living with ME and highlights the need for ongoing support and research in this important area.